Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Ansa Biotechnologies, Inc. See All Filings	D/A	2025-12-10 14:22:07 UTC
Amount To Be Raised $56,934,922 Associated Brokers / Dealers N/A CIK Number 0001816722 Filed Document 0001231919-25-000593 Exclusions or Exemptions 506b Accepted Date 2025-12-10 14:22:07 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Ansa Biotechnologies, Inc. See All Filings	D	2025-10-01 19:23:33 UTC
Amount To Be Raised $55,477,037 Associated Brokers / Dealers N/A CIK Number 0001816722 Filed Document 0001231919-25-000275 Exclusions or Exemptions 506b Accepted Date 2025-10-01 19:23:33 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Ansa Biotechnologies, Inc. See All Filings	D	2022-04-13 19:20:03 UTC
Amount To Be Raised $76,671,201 Associated Brokers / Dealers N/A CIK Number 0001816722 Filed Document 0001816722-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-04-13 19:20:03 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Ansa Biotechnologies, Inc. See All Filings	D	2021-10-15 15:10:59 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001816722 Filed Document 0001816722-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-10-15 15:10:59 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Ansa Biotechnologies, Inc. See All Filings	D	2020-07-09 13:08:14 UTC
Amount To Be Raised $9,213,151 Associated Brokers / Dealers N/A CIK Number 0001816722 Filed Document 0001816722-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-07-09 13:08:14 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity